JP2005040765A - 抗酸化性水及び抗酸化性飲料 - Google Patents
抗酸化性水及び抗酸化性飲料 Download PDFInfo
- Publication number
- JP2005040765A JP2005040765A JP2003280205A JP2003280205A JP2005040765A JP 2005040765 A JP2005040765 A JP 2005040765A JP 2003280205 A JP2003280205 A JP 2003280205A JP 2003280205 A JP2003280205 A JP 2003280205A JP 2005040765 A JP2005040765 A JP 2005040765A
- Authority
- JP
- Japan
- Prior art keywords
- water
- drink
- beverage
- antioxidant
- oxidizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 87
- 230000003064 anti-oxidating effect Effects 0.000 title abstract 7
- 230000007935 neutral effect Effects 0.000 claims abstract description 16
- 235000020124 milk-based beverage Nutrition 0.000 claims abstract description 12
- 235000013334 alcoholic beverage Nutrition 0.000 claims abstract description 8
- 235000014171 carbonated beverage Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 235000015192 vegetable juice Nutrition 0.000 claims abstract description 8
- 230000003078 antioxidant effect Effects 0.000 claims description 41
- 239000003963 antioxidant agent Substances 0.000 claims description 37
- 235000013361 beverage Nutrition 0.000 claims description 26
- 235000013616 tea Nutrition 0.000 claims description 7
- 230000033116 oxidation-reduction process Effects 0.000 abstract description 19
- 241001122767 Theaceae Species 0.000 abstract description 5
- 235000011496 sports drink Nutrition 0.000 abstract description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
- -1 lipid peroxide Chemical class 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000008399 tap water Substances 0.000 description 7
- 235000020679 tap water Nutrition 0.000 description 7
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 230000029142 excretion Effects 0.000 description 5
- 239000013535 sea water Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005868 electrolysis reaction Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 235000019543 dairy drink Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000000909 electrodialysis Methods 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- FJNCXZZQNBKEJT-UHFFFAOYSA-N 8beta-hydroxymarrubiin Natural products O1C(=O)C2(C)CCCC3(C)C2C1CC(C)(O)C3(O)CCC=1C=COC=1 FJNCXZZQNBKEJT-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000027932 Collagen disease Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000008789 oxidative DNA damage Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
Abstract
【解決手段】 本発明によれば、少なくとも、常温常圧下でpHが9.0以下6.5以上であり、酸化還元電位が−150mV以下−900mV以上の抗酸化性水及び抗酸化性飲料が提供される。
前記pHは8.5以下6.5以上であることが好ましい。
また、前記抗酸化性飲料は、スポーツ飲料、果実飲料、乳飲料、乳性飲料、茶飲料、野菜ジュース、アルコール飲料又は炭酸飲料とすることもできる。
【選択図】 図1
Description
12、12'、12" 流量調節弁
13 陽極室
14 脱イオン水室
15 陰極室
16、16' Pt電極
17、17 多孔性の隔膜
18 電圧可変直流電源
Claims (5)
- 少なくとも、常温常圧下でpHが9.0以下6.5以上であり、酸化還元電位が−150mV以下−900mV以上である中性還元水からなる抗酸化性水。
- 前記pHが8.5以下6.5以上であることを特徴とする請求項1に記載の抗酸化性水。
- 少なくとも、常温常圧下でpHが9.0以下6.5以上であり、酸化還元電位が−150mV以下−900mV以上である抗酸化性飲料。
- 前記pHが8.5以下6.5以上であることを特徴とする請求項3に記載の抗酸化性飲料。
- 前記抗酸化性飲料が、スポーツ飲料、果実飲料、乳飲料、乳性飲料、茶飲料、野菜ジュース、アルコール飲料又は炭酸飲料であることを特徴とする請求項3又は4に記載の抗酸化性飲料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003280205A JP2005040765A (ja) | 2003-07-25 | 2003-07-25 | 抗酸化性水及び抗酸化性飲料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003280205A JP2005040765A (ja) | 2003-07-25 | 2003-07-25 | 抗酸化性水及び抗酸化性飲料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2005040765A true JP2005040765A (ja) | 2005-02-17 |
Family
ID=34266102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003280205A Pending JP2005040765A (ja) | 2003-07-25 | 2003-07-25 | 抗酸化性水及び抗酸化性飲料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2005040765A (ja) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006273730A (ja) * | 2005-03-28 | 2006-10-12 | Wataru Murota | 酸素含有型還元性生理食塩水又は酸素含有型還元性輸液及びその製造方法 |
| JP2007253131A (ja) * | 2006-03-27 | 2007-10-04 | Takaoka Kasei Kogyo Kk | 抗酸化剤を含有する機能水 |
| JP2008156320A (ja) * | 2006-12-26 | 2008-07-10 | Hydrox Kk | 抗酸化性機能水 |
| JP2013068585A (ja) * | 2011-09-20 | 2013-04-18 | Ls Nova Co Ltd | 汚染された放射能物質の除去 |
| US20140178491A1 (en) * | 2011-08-04 | 2014-06-26 | Ls Nova Co., Ltd. | Multiple separation filter and antioxidizing water produced using the same |
| WO2015088378A1 (ru) * | 2013-12-09 | 2015-06-18 | Владимир Анатольевич БАРАНОВ | Непитьевой пищевой продукт неприродного происхождения |
| JP2017079606A (ja) * | 2015-10-23 | 2017-05-18 | 光騰光電股▲ふん▼有限公司 | 抗酸化機能性飲料、及び抗酸化機能性飲料の製造方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0856632A (ja) * | 1994-08-23 | 1996-03-05 | Kumamoto Pref Gov | 食品等の還元性水素水とその製造方法並びに製造装置 |
| WO2003002466A1 (en) * | 2001-06-29 | 2003-01-09 | Miz Co., Ltd. | Method for antioxidation and antioxidative functional water |
| JP2004230370A (ja) * | 2002-12-05 | 2004-08-19 | Wataru Murota | 還元水及びその製造方法 |
| JP2004329188A (ja) * | 2003-05-06 | 2004-11-25 | Wataru Murota | 還元性茶及びその製造方法 |
| JP2004351399A (ja) * | 2003-05-26 | 2004-12-16 | Wataru Murota | 還元水及びその製造方法 |
-
2003
- 2003-07-25 JP JP2003280205A patent/JP2005040765A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0856632A (ja) * | 1994-08-23 | 1996-03-05 | Kumamoto Pref Gov | 食品等の還元性水素水とその製造方法並びに製造装置 |
| WO2003002466A1 (en) * | 2001-06-29 | 2003-01-09 | Miz Co., Ltd. | Method for antioxidation and antioxidative functional water |
| JP2004230370A (ja) * | 2002-12-05 | 2004-08-19 | Wataru Murota | 還元水及びその製造方法 |
| JP2004329188A (ja) * | 2003-05-06 | 2004-11-25 | Wataru Murota | 還元性茶及びその製造方法 |
| JP2004351399A (ja) * | 2003-05-26 | 2004-12-16 | Wataru Murota | 還元水及びその製造方法 |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006273730A (ja) * | 2005-03-28 | 2006-10-12 | Wataru Murota | 酸素含有型還元性生理食塩水又は酸素含有型還元性輸液及びその製造方法 |
| JP2007253131A (ja) * | 2006-03-27 | 2007-10-04 | Takaoka Kasei Kogyo Kk | 抗酸化剤を含有する機能水 |
| JP2008156320A (ja) * | 2006-12-26 | 2008-07-10 | Hydrox Kk | 抗酸化性機能水 |
| US20140178491A1 (en) * | 2011-08-04 | 2014-06-26 | Ls Nova Co., Ltd. | Multiple separation filter and antioxidizing water produced using the same |
| EP2740523A4 (en) * | 2011-08-04 | 2015-08-19 | Ls Nova Co Ltd | MULTIPLE SEPARATION FILTER AND ANTIOXIDANT WATER PRODUCED USING THE FILTER |
| US9255016B2 (en) * | 2011-08-04 | 2016-02-09 | Ls Nova Co., Ltd. | Multiple separation filter and antioxidizing water produced using the same |
| JP2013068585A (ja) * | 2011-09-20 | 2013-04-18 | Ls Nova Co Ltd | 汚染された放射能物質の除去 |
| WO2015088378A1 (ru) * | 2013-12-09 | 2015-06-18 | Владимир Анатольевич БАРАНОВ | Непитьевой пищевой продукт неприродного происхождения |
| JP2017079606A (ja) * | 2015-10-23 | 2017-05-18 | 光騰光電股▲ふん▼有限公司 | 抗酸化機能性飲料、及び抗酸化機能性飲料の製造方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5640266B1 (ja) | 電解水製造装置及びこれを用いる電解水の製造方法 | |
| KR100972897B1 (ko) | 환원수 및 그 제조 방법 | |
| JPH09262583A (ja) | 酸性水及びアルカリ性水の製造方法 | |
| JP2005040765A (ja) | 抗酸化性水及び抗酸化性飲料 | |
| CN203833687U (zh) | 健康饮水机 | |
| JP3632839B2 (ja) | 生体水に類似する水の製造法 | |
| KR20120114900A (ko) | 전해 환원수 제조 장치 | |
| JP2007007502A (ja) | 低食塩電解水の製造方法とその製造装置 | |
| JP2005041848A (ja) | 生理活性を有する機能性水及び機能性飲料 | |
| KR20130040627A (ko) | 전해 환원수 제조장치 | |
| JP3705756B2 (ja) | 電解液及び該電解液により生成させた電解水 | |
| JP2002018439A (ja) | ビタミンc入りアルカリ性電解水 | |
| JP2004313780A (ja) | 過酢酸の電解合成方法及び殺菌洗浄方法及び装置 | |
| TW490445B (en) | Reducing electrolytic water producing method | |
| JP3205698B2 (ja) | アルカリ性電解水 | |
| JP4130763B2 (ja) | 非酸化性強酸性水の生成方法 | |
| JP2001246383A (ja) | 電解水生成装置 | |
| CN111560623B (zh) | 一种连续稳定制备次氯酸的方法 | |
| JP3163726U (ja) | ボトルドウォーターを原水とする飲用電解水装置 | |
| CN101115686A (zh) | 还原性冰和使用该冰制造还原性液体的方法 | |
| JP2005125276A (ja) | 殺菌性電解水の製造装置 | |
| KR100658409B1 (ko) | 양극 전해수 및 그 제조방법 | |
| US20110068000A1 (en) | Drinking electrolytic water apparatus using bottled water as raw water | |
| WO2013064695A2 (en) | Process for preparing an anolyte liquid | |
| HK1110299A (en) | Reducing ice and process for producing reducing liquid with use of the ice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041203 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060728 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060728 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080410 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080729 |